Zygomatic implants placed in atrophic maxilla: an overview of current systematic reviews and meta-analysis

Abstract Background Zygomatic implants are a treatment option for severely atrophic maxilla. Main text This study aimed to summarize and evaluate systematic reviews assessing the clinical outcomes of zygomatic implants including survival/failure rate and complications. PubMed-MEDLINE, Google Scholar...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaqayeq Ramezanzade (Author), Julian Yates (Author), Frank J. Tuminelli (Author), Seied Omid Keyhan (Author), Parisa Yousefi (Author), Jose Lopez-Lopez (Author)
Format: Book
Published: SpringerOpen, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_171efc9d2e1140dfbfd6488e8974cf81
042 |a dc 
100 1 0 |a Shaqayeq Ramezanzade  |e author 
700 1 0 |a Julian Yates  |e author 
700 1 0 |a Frank J. Tuminelli  |e author 
700 1 0 |a Seied Omid Keyhan  |e author 
700 1 0 |a Parisa Yousefi  |e author 
700 1 0 |a Jose Lopez-Lopez  |e author 
245 0 0 |a Zygomatic implants placed in atrophic maxilla: an overview of current systematic reviews and meta-analysis 
260 |b SpringerOpen,   |c 2021-01-01T00:00:00Z. 
500 |a 10.1186/s40902-020-00286-z 
500 |a 2288-8586 
520 |a Abstract Background Zygomatic implants are a treatment option for severely atrophic maxilla. Main text This study aimed to summarize and evaluate systematic reviews assessing the clinical outcomes of zygomatic implants including survival/failure rate and complications. PubMed-MEDLINE, Google Scholar, LILACS, and the Cochrane Database were searched up to April 2020. Risk of bias assessment was conducted by the AMSTAR tool. Initial searches yielded 175 studies. These were assessed, and following title abstract and full-text evaluation, 7 studies (2 meta-analyses) were included in the final review. According to the AMSTAR tool, 1 was deemed high quality, 4 were classified as medium, and 2 as low quality. The mean AMSTAR score (±SD) was 5.28 of 9 (±2.36) ranging from 2/9 to 9/9. The reported survival rates ranged from 95.2 to 100% except for resected maxillas, which established higher failure rates up to 21.43%. Concerning the complications with the zygomatic implants, various surgical and prosthetic complications were reported with sinusitis being the most frequently observed complication. Zygomatic implants appears to offer a promising alternative to formal bone grafting techniques with lower costs, less complications, less morbidity, shorter treatment times, and comparably high survival rates. Conclusion Complications were rare and usually easy to manage. However, the treatment should be directed by appropriately trained clinicians with noticeable surgical experience. 
546 |a EN 
690 |a Umbrella review 
690 |a Zygomatic implant 
690 |a Atrophic 
690 |a Zygomatic 
690 |a Dentistry 
690 |a RK1-715 
690 |a Surgery 
690 |a RD1-811 
655 7 |a article  |2 local 
786 0 |n Maxillofacial Plastic and Reconstructive Surgery, Vol 43, Iss 1, Pp 1-15 (2021) 
787 0 |n https://doi.org/10.1186/s40902-020-00286-z 
787 0 |n https://doaj.org/toc/2288-8586 
856 4 1 |u https://doaj.org/article/171efc9d2e1140dfbfd6488e8974cf81  |z Connect to this object online.